Kailera Therapeutics, Inc. (NASDAQ:KLRA) IPO

Kailera Therapeutics, Inc.

IPO

Priced at US$16.00 a share on Apr 16, 2026.

Price
US$16.00 a share
Shares offered
39,062,500 shares of common stock
Offering size
US$625 million
Underwriters' option
Up to 5,859,375 more shares
Listing
KLRA on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, Evercore ISI, William Blair · In the order on the cover
Shares delivered
On or about Apr 20, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceDec 19, 2025
Filed publiclyMar 27, 2026
Amended onceApr 13, 2026
Shares registered with an exchangeApr 14, 2026
Declared effective by the SECApr 16, 2026
Final prospectus, with the priceApr 17, 2026

From the cover of the final prospectus (424B4) filed Apr 17, 2026